Results 131 to 140 of about 178,392 (266)

Upright and supine particle therapy of lung cancer: A 4D dosimetric comparison. [PDF]

Med Phys
Martire MC, Volz L, Durante M, Pankuch M, Graeff C.   +4 more
europepmc   +1 more source

Targeting CD300a Signaling With a Phosphatidylserine‐Presenting Hydrogel Rescues Macrophage Dysfunction and Accelerates Diabetic Wound Healing

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the proposed mechanism: PEG/RGD‐PSLs mimic apoptotic cells to engage PS receptors (notably CD300a), transducing an inhibitory signal that suppresses the MyD88/NF‐κB pathway, leading to global anti‐inflammatory and pro‐reparative effects.
Lele Wu, Xuetong Hao, Yang Zou, Xinglin Chen, Junyan Kong, Chunning Gu, Wenjie Ma, Zhongjun Yang, Huifen Liu, Mengmeng Liu, Xin Tong   +10 more
wiley   +1 more source

Particle therapy

, 2019
Daniel Bell, Arlene Campos, Andrew Murphy   +2 more
openaire   +1 more source

PTCOG Ocular Survey - Perspective on Ocular Particle Therapy: Current Practices and Emerging Trends. [PDF]

Int J Part Ther
Mortimer L, Slopsema R, Mazal A, Beenakker JW, Dendale R, Denker A, Fleury E, Groulier A, Kacperek A, Mishra KK, Saini J, Trofimov AV, Thariat J, Trnková P, Vidal M, Shih HA, Hrbacek J, Heufelder J.   +17 more
europepmc   +1 more source

Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction

Advanced Healthcare Materials, EarlyView.
FeS‐VA@lanifibranor (FVL), an activated hepatic stellate cell (aHSC)‐targeted nanoplatform comprising vitamin A‐functionalized two‐dimensional iron sulfide nanosheets and lanifibranor, is engineered for precision therapy of liver fibrosis. FVL suppresses the TGF‐β signaling pathway by inhibiting SMAD2/3 phosphorylation and induces ferroptosis in aHSCs,
Yinuo Yang, Mengyao Mu, Ke Ren, Hui Liu, Pengju Ma, Yingqi Wang, Mengmeng Zhang, Xueli Xu, Wenzhe Li, Wenshuang Gao, Xiao Sun, Qiang Zhu   +11 more
wiley   +1 more source

Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact. [PDF]

Cancer Med
Mizumoto M, Shibuya K, Terashima K, Iwata H, Saito T, Toyama S, Ogino T, Murakami M, Ohno T, Sato Y, Akimoto T, Katoh H, Wakatsuki M, Waki T, Katoh N, Koizumi F, Araya M, Onoe T, Takagi M, Okimoto T, Ogino H, Numajiri H, Shioyama Y, Hashimoto T, Ohba H, Kubo S, Hasegawa K, Maruo K, Aoyama H, Sakurai H.   +29 more
europepmc   +1 more source

Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy. [PDF]

Clin Mol Hepatol, 2023
Yoon SM.
europepmc   +1 more source

Hydrophilic Polymers Enable Gastrointestinal Transit Monitoring by Fluorine‐19 Magnetic Resonance Imaging

Advanced Healthcare Materials, EarlyView.
Hydrophilic fluorinated copolymers dissolve in chyme and give a strong, single 19F signal, unlike phase‐separating perfluorocarbons. Combined 1H‐19F MRI tracks their whole‐gut transit non‐invasively and without ionizing radiation. In rats, the tracers move through the gastrointestinal tract, resist resorption, and are well tolerated, a proof‐of‐concept
Ondřej Groborz, Vít Herynek, Mária Hovořáková, Zuzana Pavlíková, Linda Dalecká, Klára Steklíková, Petr Matouš, Petr Páral, Margarita Tkachenko, Filip Koucký, Fatma Nalan Cetin, Ludmila Maffei Svobodová, Jiří Beneš, Kristýna Kolouchová   +13 more
wiley   +1 more source

Development and Validation of an Interface Between the BIANCA Biophysical Model and Geant4 for Particle Therapy. [PDF]

Biomedicines
Carante MP, Madonnini A, Casali A, Canay EI, Ramos RL, Ballarini F.   +5 more
europepmc   +1 more source

Editorial: Targeted alpha particle therapy in oncology. [PDF]

Front Med (Lausanne), 2023
Bruland ØS, Larsen RH, Baum RP, Juzeniene A.   +3 more
europepmc   +1 more source